These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28438355)

  • 1. Early and frequent defibrillator discharge in patients with cardiac sarcoidosis compared with patients with idiopathic dilated cardiomyopathy.
    Takaya Y; Kusano K; Nishii N; Nakamura K; Ito H
    Int J Cardiol; 2017 Aug; 240():302-306. PubMed ID: 28438355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac sarcoidosis: electrophysiological outcomes on long-term follow-up and the role of the implantable cardioverter-defibrillator.
    Mohsen A; Jimenez A; Hood RE; Dickfeld T; Saliaris A; Shorofsky S; Saba MM
    J Cardiovasc Electrophysiol; 2014 Feb; 25(2):171-6. PubMed ID: 24433308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.
    Kron J; Sauer W; Schuller J; Bogun F; Crawford T; Sarsam S; Rosenfeld L; Mitiku TY; Cooper JM; Mehta D; Greenspon AJ; Ortman M; Delurgio DB; Valadri R; Narasimhan C; Swapna N; Singh JP; Danik S; Markowitz SM; Almquist AK; Krahn AD; Wolfe LG; Feinstein S; Ellenbogen KA
    Europace; 2013 Mar; 15(3):347-54. PubMed ID: 23002195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appropriate ICD therapy in patients with idiopathic dilated cardiomyopathy: long term follow-up.
    Karaoguz R; Maydanozcu S; Altun T; Güldal M; Akyürek O; Erol C
    Int Heart J; 2006 Sep; 47(5):763-73. PubMed ID: 17106147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of renal dysfunction on appropriate therapy in implantable cardioverter defibrillator patients with non-ischaemic dilated cardiomyopathy.
    Takahashi A; Shiga T; Shoda M; Manaka T; Ejima K; Hagiwara N
    Europace; 2009 Nov; 11(11):1476-82. PubMed ID: 19661116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication.
    Schaer B; Kühne M; Reichlin T; Osswald S; Sticherling C
    Europace; 2016 Feb; 18(2):227-31. PubMed ID: 26063686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.
    Gatzoulis KA; Vouliotis AI; Tsiachris D; Salourou M; Archontakis S; Dilaveris P; Gialernios T; Arsenos P; Karystinos G; Sideris S; Kallikazaros I; Stefanadis C
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):504-12. PubMed ID: 23588627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. J Waves Are Associated With the Increased Occurrence of Life-Threatening Ventricular Tachyarrhythmia in Patients With Nonischemic Cardiomyopathy.
    Naruse Y; Nogami A; Shinoda Y; Hanaki Y; Shirai Y; Kowase S; Kurosaki K; Machino T; Kuroki K; Yamasaki H; Igarashi M; Sekiguchi Y; Aonuma K
    J Cardiovasc Electrophysiol; 2016 Dec; 27(12):1448-1453. PubMed ID: 27593399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular function improvement after prophylactic implantable cardioverter-defibrillator implantation in patients with non-ischaemic dilated cardiomyopathy.
    Grimm W; Timmesfeld N; Efimova E
    Europace; 2013 Nov; 15(11):1594-600. PubMed ID: 23639855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis.
    Schuller JL; Zipse M; Crawford T; Bogun F; Beshai J; Patel AR; Sweiss NJ; Nguyen DT; Aleong RG; Varosy PD; Weinberger HD; Sauer WH
    J Cardiovasc Electrophysiol; 2012 Sep; 23(9):925-9. PubMed ID: 22812589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of Patients With Cardiac Sarcoidosis Who Received Cardiac Resynchronization Therapy: Comparison With Dilated Cardiomyopathy Patients.
    Yufu K; Kondo H; Shinohara T; Kawano K; Ishii Y; Miyoshi M; Imamura T; Saito S; Okada N; Akioka H; Teshima Y; Nakagawa M; Takahashi N
    J Cardiovasc Electrophysiol; 2017 Feb; 28(2):177-181. PubMed ID: 27862596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of implantable cardioverter-defibrillator implantation in secondary prevention of sudden cardiac death.
    Boulé S; Sémichon M; Guédon-Moreau L; Drumez É; Kouakam C; Marquié C; Brigadeau F; Kacet S; Potelle C; Escande W; Souissi Z; Lacroix D; Duhamel A; Klug D
    Arch Cardiovasc Dis; 2016 Oct; 109(10):517-526. PubMed ID: 27342808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators.
    Betensky BP; Tschabrunn CM; Zado ES; Goldberg LR; Marchlinski FE; Garcia FC; Cooper JM
    Heart Rhythm; 2012 Jun; 9(6):884-91. PubMed ID: 22338670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of patients with definite and suspected isolated cardiac sarcoidosis treated with an implantable cardiac defibrillator.
    Kron J; Sauer W; Mueller G; Schuller J; Bogun F; Sarsam S; Rosenfeld L; Mitiku TY; Cooper JM; Mehta D; Greenspon AJ; Ortman M; Delurgio DB; Valadri R; Narasimhan C; Swapna N; Singh JP; Danik S; Markowitz SM; Almquist AK; Krahn AD; Wolfe LG; Feinstein S; Ellenbogen KA; Crawford T
    J Interv Card Electrophysiol; 2015 Jun; 43(1):55-64. PubMed ID: 25676929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of implantable cardioverter-defibrillator on left ventricular ejection fraction in patients with idiopathic dilated cardiomyopathy.
    Schaer B; Theuns DA; Sticherling C; Szili-Torok T; Osswald S; Jordaens L
    Am J Cardiol; 2010 Dec; 106(11):1640-5. PubMed ID: 21094367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease in amplitude of intracardiac ventricular electrogram and inappropriate therapy in patients with an implantable cardioverter defibrillator.
    Watanabe H; Chinushi M; Izumi D; Sato A; Okada S; Okamura K; Komura S; Hosaka Y; Furushima H; Washizuka T; Aizawa Y
    Int Heart J; 2006 May; 47(3):363-70. PubMed ID: 16823242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of entirely subcutaneous ICD™ systems in patients with dilated cardiomyopathy.
    Willy K; Reinke F; Bögeholz N; Ellermann C; Rath B; Köbe J; Eckardt L; Frommeyer G
    J Cardiol; 2020 May; 75(5):567-570. PubMed ID: 31744658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of diabetes mellitus on inappropriate and appropriate implantable cardioverter-defibrillator therapy and mortality in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Trial.
    Ruwald MH; Zareba W; Jons C; Zhang C; Ruwald AC; Olshansky B; McNitt S; Bloch Thomsen PE; Shoda M; Merkely B; Moss AJ; Kutyifa V
    Circulation; 2013 Aug; 128(7):694-701. PubMed ID: 23881862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid-rate nonsustained ventricular tachycardias in high-risk dilated cardiomyopathy patients.
    Lee WC; Watanabe M; Yokoshiki H; Temma T; Kamada R; Takahashi M; Hagiwara H; Takahashi Y; Anzai T
    Pacing Clin Electrophysiol; 2020 Oct; 43(10):1086-1095. PubMed ID: 32735041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.